Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,327Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Osimertinib Mesylate

Brand Name : TAGRISSO

Patent Number : 2843109

Filing Date : 2012-07-25

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-07-25

Date Granted : 2015-06-16

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Osimertinib Mesylate

Brand Name : TAGRISSO

Patent Number : 2843109

Filing Date : 2012-07-25

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-07-25

Date Granted : 2015-06-16

blank